EMMAC Life Sciences Related News
EMMAC Life Sciences and its successful issue of Convertible Loan Notes
EMMAC Life Sciences Group, Europe’s leading independent cannabis company, is pleased to announce it has raised £15 million via an issue of Convertible Loan...
Imperial College London expands its cannabis research programme
Imperial College London and research partner EMMAC will be expanding a cannabis research programme that aims to evaluate the ‘entourage effect’ of cannabinoids for...
EMMAC Life Sciences Ltd announces acquisition of French wellness company, GreenLeaf
EMMAC Life Sciences Ltd, the European medical cannabis company, is pleased to announce the acquisition of GreenLeaf, a French wellness company specialising in hemp-based...
Results through research: shaping the future of medical cannabis
Discover how, together, EMMAC Life Sciences and Imperial College London are advancing our understanding of the therapeutic properties of medical cannabis for a range...
A budding industry: How EMMAC Life Sciences is growing the medical cannabis industry across...
EMMAC Life Sciences’ Antonio Costanzo discusses the booming medical cannabis industry in Europe and EMMAC’s role in its future.
As investment and interest in the...
